Differential impairment of aspirin-dependent platelet cyclooxygenase acetylation by nonsteroidal antiinflammatory drugs. - Wikidata - wikimedia - TriplyDB

Differential impairment of aspirin-dependent platelet cyclooxygenase acetylation by nonsteroidal antiinflammatory drugs.

Differential impairment of aspirin-dependent platelet cyclooxygenase acetylation by nonsteroidal antiinflammatory drugs.

http://www.wikidata.org/entity/Q34601141

about

Mass spectrometry-based approaches to targeted quantitative proteomics in cardiovascular disease In microfluidico: Recreating in vivo hemodynamics using miniaturized devices Microfluidic whole blood testing of platelet response to pharmacological agents.Nonsteroidal anti-inflammatory drugs and cardiovascular safety - translating pharmacological data into clinical readouts.Ex vivo recapitulation of trauma-induced coagulopathy and preliminary assessment of trauma patient platelet function under flow using microfluidic technology Systems Analysis of Thrombus Formation.Effects of Oxidative Stress and Testosterone on Pro-Inflammatory Signaling in a Female Rat Dopaminergic Neuronal Cell Line A broad-spectrum lipidomics screen of antiinflammatory drug combinations in human blood.Cardiovascular effects of cyclooxygenase-2 inhibitors: a mechanistic and clinical perspective.Is arachidonic acid stimulation really a test for the response to aspirin? Time to think again?Coxibs, Traditional NSAIDs, and Cardiovascular Safety Post-PRECISION: What We Thought We Knew Then and What We Think We Know Now.The Cardiovascular Pharmacology of Nonsteroidal Anti-Inflammatory Drugs.Antiplatelet agents for cancer treatment: a real perspective or just an echo from the past?Nonsteroidal anti-inflammatory drug choice and adverse outcomes in clopidogrel users: A retrospective cohort study.Low-Dose Aspirin Acetylates Cyclooxygenase-1 in Human Colorectal Mucosa: Implications for the Chemoprevention of Colorectal Cancer.Studying additive interaction in a healthcare database: Case study of NSAIDs, cardiovascular profiles, and acute myocardial infarction

P2860

Q28075372-597B39C1-DB16-496B-A6C5-769364677065 Q28084800-EBD0A565-DE71-46AA-825C-91737DE67F9A Q36253661-143EB0DE-900F-4310-B352-6B559B964741 Q36388949-A93E1EE7-C2BB-445E-AF12-D9B25D693B36 Q36807483-88CFC23B-E446-45D3-A4E3-4CD4B357E32E Q36855652-246D62D5-2929-47A9-93AD-5D4F675F2F01 Q37057444-1E0A356A-EEF5-4BDC-A46D-3612A6559340 Q37187622-B56A2606-AC5E-43B4-9342-3C32679BAA89 Q38851488-40612D81-8B72-403D-AAEA-7BF09251BDF1 Q39021950-6A79F11B-FD2B-47D4-BD90-AA17BA249412 Q39221288-93A63ED3-48F6-41C9-B76F-05EB15B8EEB9 Q39399193-F86F7D0B-4E52-4A3A-9F3F-232D14E3ABA5 Q41420993-3A2B47FE-E99A-4B69-8104-B17566CA867F Q52655970-377B8B42-A84D-4BAA-B8C8-98D0534F6F26 Q53528564-0ED94028-F07C-4FF2-AB46-7A88BEEB4B0C Q58791320-7EA94A99-F3E0-40F3-A490-49383028E7EC

P2860

Differential impairment of aspirin-dependent platelet cyclooxygenase acetylation by nonsteroidal antiinflammatory drugs.

http://www.wikidata.org/entity/Q34601141

description

2014 nî lūn-bûn

@nan

2014 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Differential impairment of asp ...... roidal antiinflammatory drugs.

@ast

Differential impairment of asp ...... roidal antiinflammatory drugs.

@en

Differential impairment of asp ...... roidal antiinflammatory drugs.

@nl

type

label

Differential impairment of asp ...... roidal antiinflammatory drugs.

@ast

Differential impairment of asp ...... roidal antiinflammatory drugs.

@en

Differential impairment of asp ...... roidal antiinflammatory drugs.

@nl

prefLabel

Differential impairment of asp ...... roidal antiinflammatory drugs.

@ast

Differential impairment of asp ...... roidal antiinflammatory drugs.

@en

Differential impairment of asp ...... roidal antiinflammatory drugs.

@nl

P1433

Q34601141-B91535B9-3689-4B16-99A0-DB6BAEA56B16

P1476

Q34601141-E61F0DCA-D501-4A4B-9CD0-85935CC98AE0

P2093

Q34601141-166C4A60-8524-4BA5-AFA1-E38E0D6C1413

Q34601141-31A32FDB-7B38-4D46-95E0-B846016D9364

Q34601141-39ECA906-0902-41A3-9A31-6537ABFD397A

Q34601141-594AA317-9AC3-45BD-8052-D0323247F500

Q34601141-608E1C94-4C11-462F-8217-2313DDD6293C

Q34601141-637F4529-22E1-48DF-8BE7-099BE68E648A

Q34601141-851003E1-C489-4735-B14D-9B4019B88807

Q34601141-AFD89435-701C-4C3B-99A9-1BBA559689DD

P2860

Q34601141-0216EE6E-176C-4ECF-92B4-6BEB0A39FFAB

Q34601141-09414181-67CE-43B1-BC67-05B62867C851

Q34601141-0C7B9BD8-C939-4249-BB69-882E7E2604A7

Q34601141-11B422E5-9C1B-4A06-99A5-9B0EFAB3BB1E

Q34601141-17C44D4B-A91C-47BC-9639-1045082D2BD6

Q34601141-185D4722-61EA-453E-9749-2223D8C5B4AE

Q34601141-23DB4AC0-4B1E-4617-895F-72ED18B54CB3

Q34601141-43332185-FAD5-4C5B-AE5C-70BD0C49C416

Q34601141-4BD2B6C3-C48F-42CA-83D1-7CA8FAEF5EEB

Q34601141-5BAB7A69-95E0-4DE3-BA37-FB0DB771C95C

P304

Q34601141-A8EC0EC6-121D-4522-A2FF-863F4D5B122E

P31

Q34601141-A3946B66-E0AF-4250-A50F-8F43F4EEA353

P356

Q34601141-1877B4FE-65B7-4096-AF9C-0F1AD4D1E207

P407

Q34601141-699CB9FE-F555-443E-B709-8B43BB050AF1

P433

Q34601141-0ABCA109-EB81-49B9-B64F-5ECE5F263A1D

P478

Q34601141-FCD4572F-33BB-43DE-8540-CF5B6F3F5714

P50

Q34601141-98366351-E052-44C5-8D7E-530D918DCEF5

P577

Q34601141-34D2C22E-07C5-465F-B575-E035099E47A3

P5875

Q34601141-98818147-BB7D-44FD-BE7B-6A0719B5BE06

P698

Q34601141-54C16849-DBD3-4C8B-B280-DA4797803D6F

P921

Q34601141-CC522F2F-81B9-4AAD-8C23-0647A4357ED9

P932

Q34601141-8FEE9EB5-3D7D-48E9-B3A0-CC6326C3453D

P356

PNAS.1406997111

P1433

Proceedings of the National Academy of Sciences of the United States of America

P1476

Differential impairment of asp ...... roidal antiinflammatory drugs.

@en

P2093

Garret A FitzGerald

http://www.w3.org/2001/XMLSchema#string

Ian A Blair

http://www.w3.org/2001/XMLSchema#string

John A Lawson

http://www.w3.org/2001/XMLSchema#string

Kathleen J Propert

http://www.w3.org/2001/XMLSchema#string

Ruizhi Li

http://www.w3.org/2001/XMLSchema#string

Scott L Diamond

http://www.w3.org/2001/XMLSchema#string

Susanne Fries

http://www.w3.org/2001/XMLSchema#string

Xuanwen Li

http://www.w3.org/2001/XMLSchema#string

P2860

Drug Resistance and Pseudoresistance: An Unintended Consequence of Enteric Coating Aspirin

Do selective cyclo-oxygenase-2 inhibitors and traditional non-steroidal anti-inflammatory drugs increase the risk of atherothrombosis? Meta-analysis of randomised trials

Vascular and upper gastrointestinal effects of non-steroidal anti-inflammatory drugs: meta-analyses of individual participant data from randomised trials

Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials

Coxibs interfere with the action of aspirin by binding tightly to one monomer of cyclooxygenase-1

Pharmacodynamic interaction of naproxen with low-dose aspirin in healthy subjects

Prostaglandin H synthase-2 inhibitors interfere with prostaglandin H synthase-1 inhibition by nonsteroidal anti-inflammatory drugs

Cyclooxygenase inhibitors and the antiplatelet effects of aspirin

Drug testing. Massive trial of Celebrex seeks to settle safety concerns

Comparison of lumiracoxib with naproxen and ibuprofen in the Therapeutic Arthritis Research and Gastrointestinal Event Trial (TARGET), cardiovascular outcomes: randomised controlled trial

P304

16830-16835

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1073/PNAS.1406997111

http://www.w3.org/2001/XMLSchema#string

P407

P433

47

http://www.w3.org/2001/XMLSchema#string

P478

111

http://www.w3.org/2001/XMLSchema#string

P50

P577

2014-11-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

268228605

http://www.w3.org/2001/XMLSchema#string

P698

25385584

http://www.w3.org/2001/XMLSchema#string

P921

P932

4250103

http://www.w3.org/2001/XMLSchema#string